Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avadel Pharmaceuticals (AVDL) Assets Average: 2009-2021

Historic Assets Average for Avadel Pharmaceuticals (AVDL) over the last 13 years, with Dec 2021 value amounting to $279.5 million.

  • Avadel Pharmaceuticals' Assets Average fell 44.45% to $151.8 million in Q3 2022 from the same period last year, while for Sep 2022 it was $151.8 million, marking a year-over-year decrease of 44.45%. This contributed to the annual value of $279.5 million for FY2021, which is 20.69% up from last year.
  • According to the latest figures from FY2021, Avadel Pharmaceuticals' Assets Average is $279.5 million, which was up 20.69% from $231.5 million recorded in FY2020.
  • Avadel Pharmaceuticals' 5-year Assets Average high stood at $279.5 million for FY2021, and its period low was $170.9 million during FY2019.
  • Its 3-year average for Assets Average is $227.3 million, with a median of $231.5 million in 2020.
  • As far as peak fluctuations go, Avadel Pharmaceuticals' Assets Average decreased by 22.96% in 2019, and later spiked by 35.51% in 2020.
  • Avadel Pharmaceuticals' Assets Average (Yearly) stood at $249.4 million in 2017, then declined by 11.06% to $221.8 million in 2018, then fell by 22.96% to $170.9 million in 2019, then surged by 35.51% to $231.5 million in 2020, then climbed by 20.69% to $279.5 million in 2021.